Freidenrich Center for Translational Research (CTRU) — Palo Alto, California

Freidenrich Center for Translational Research (CTRU) is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Freidenrich Center for Translational Research (CTRU) has participated in 2 clinical trials.

Therapeutic areas: Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Hematologic Malignancies, Solid Tumor.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Freidenrich Center for Translational Research (CTRU)?

Freidenrich Center for Translational Research (CTRU) has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Freidenrich Center for Translational Research (CTRU) conducted?

Freidenrich Center for Translational Research (CTRU) has 2 clinical trials on record. Their work covers Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Hematologic Malignancies, Solid Tumor.

Is Freidenrich Center for Translational Research (CTRU) accredited by Crixeo Health?

Freidenrich Center for Translational Research (CTRU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Freidenrich Center for Translational Research (CTRU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.